GlassScriptPhysician profile
Roderick D Woods
NPI 1306929633
$1,175.07
in general payments reported to CMS, 2019-2025
16 companies · $81.31 in 2025
The $81.31 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $144 · 2021: $366 · 2022: $66.89 · 2023: $301 · 2024: $216 · 2025: $81.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $282.16 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $136.94 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $107.65 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $107.54 | 2021-2024 | Farxiga |
| Pfizer INC. | $90.73 | 2020-2025 | |
| Amgen INC. | $78.41 | 2023-2024 | Repatha |
| Boston Scientific Corporation | $76.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $64.44 | 2021 | |
| Abiomed | $52.49 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.45 | 2023-2024 | Lifevest |
| Scpharmaceuticals INC. | $35.17 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $24.49 | 2023 | Camzyos |
| Genzyme Corporation | $24.47 | 2025 | |
| Irhythm Technologies, INC. | $24.06 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.23 | 2023 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $15.28 | 2023 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.